Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
39 hedge funds and large institutions have $36.2M invested in Decibel Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 4 closing their positions.
9,600% more call options, than puts
Call options by funds: $291K | Put options by funds: $3K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
3% less funds holding
Funds holding: 40 → 39 (-1)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
42% less capital invested
Capital invested by funds: $62.1M → $36.2M (-$25.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$523K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$274K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$152K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$92.1K |
| 5 |
E
Ergoteles
New York
|
+$71.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$820K |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$737K |
| 3 |
BlackRock
New York
|
-$249K |
| 4 |
Neuberger Berman Group
New York
|
-$159K |
| 5 |
NM
Newtyn Management
New York
|
-$91.4K |
DBTX Hedge Fund Activity: Q4 2022 in Review
39 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q4 2022, worth a combined $36.2M — down 42% from $62.1M a quarter earlier.
Fund positioning in DBTX was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 9 added to existing stakes and 12 trimmed.
The largest buyer was Millennium Management, adding an estimated $523K. The largest seller was EAM Investors, exiting entirely with an estimated $820K sold.
- 39 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q4 2022, down from 40 in Q3 2022.
- Funds reported $36.2M of Decibel Therapeutics, Inc. Common Stock stock for Q4 2022, down 42% quarter-over-quarter.
- 4 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q4 2022 and 4 closed out, a net change of 0 holders.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q4 2022 was Millennium Management, an estimated $523K added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q4 2022 was EAM Investors, an estimated $820K sold.
Based on aggregated 13F filings for Q4 2022.